EVH
Evolent Health, Inc. · Healthcare · Medical - Healthcare Information Services
Momentum-Eingaben (vergleichbare Manager):
Halterbreite +7.7% ·
Aktienfluss -8.0% ·
neue Nettopositionen +7.1%
— Formel
Eigentümerfragmentierung — mehr Halter, kleinere Gesamtbeteiligung
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q4 2024
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q2 2026 | 78 | +6 | 70.64M | $382.54M | +11 | −4 |
| Q1 2026 | 73 | -12 | 65.20M | $148.81M | +7 | −20 |
| Q4 2025 | 86 | 0 | 77.77M | $307.90M | +1 | — |
| Q3 2025 | 19 | +1 | 60.10M | $508.46M | +2 | −2 |
| Q2 2025 | 16 | -1 | 36.98M | $416.34M | — | −1 |
| Q1 2025 | 14 | 0 | 22.70M | $214.97M | +1 | −1 |
| Q4 2024 | 14 | +1 | 27.38M | $247.73M | +1 | — |
| Q3 2024 | 12 | 0 | 21.00M | $593.78M | +1 | −1 |
| Q2 2024 | 12 | — | 19.79M | $378.42M | — | — |
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 10.44M | -17.1% | $117.41M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 2 | Wellington Management ✦ | 10.44M | -17.1% | $117.41M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 3 | Wellington Management ✦ | 10.44M | -17.1% | $117.41M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 4 | Wellington Management ✦ | 10.44M | -17.1% | $117.41M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 5 | State Street Global Advisors ✦ (passiv) | 8.76M | — | $38.26M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | State Street Global Advisors ✦ (passiv) | 8.76M | — | $38.26M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Geode Capital Management ✦ (passiv) | 2.51M | -0.3% | $28.29M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 8 | Geode Capital Management ✦ (passiv) | 2.51M | -0.3% | $28.29M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 9 | Millennium Management ✦ | 1.26M | +198.7% | $14.12M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 10 | Norges Bank ✦ (passiv) | 1.11M | -17.4% | $12.52M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 11 | Adage Capital Partners ✦ | 844.50K | -40.5% | $9.50M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 12 | T. Rowe Price ✦ | 744.45K | +4.0% | $8.38M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 13 | T. Rowe Price ✦ | 744.45K | +4.0% | $8.38M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 14 | D. E. Shaw & Co. ✦ | 623.07K | Neu | $7.01M | 0.0% | New | 1 | SEC ↗ |
| 15 | D. E. Shaw & Co. ✦ | 623.07K | Neu | $7.01M | 0.0% | New | 1 | SEC ↗ |
| 16 | Citadel Advisors ✦ | 482.02K | +142.9% | $5.42M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 17 | Point72 Asset Management ✦ | 281.14K | -81.2% | $3.16M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 18 | GAMCO Investors ✦ | 197.10K | +43.8% | $2.22M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 19 | Marshall Wace ✦ | 94.32K | +45.1% | $1.06M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 20 | Marshall Wace ✦ | 94.32K | +45.1% | $1.06M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 21 | Marshall Wace ✦ | 94.32K | +45.1% | $1.06M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 22 | Bridgewater Associates ✦ | 21.12K | -70.9% | $237,578 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 23 | AQR Capital Management ✦ | 11.95K | +66.2% | $134,484 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 24 | AQR Capital Management ✦ | 11.95K | +66.2% | $134,484 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 25 | AQR Capital Management ✦ | 11.95K | +66.2% | $134,484 | 0.0% | ▲ Add | 2 | SEC ↗ |
„Ihre Gewichtung" = Anteil der Position am gemeldeten 13F-Eigenkapitalwert des jeweiligen Managers — das Conviction-Maß. ✦ = kuratorisch ausgewählter Manager.
Neue Käufer
| D. E. Shaw & Co. | $7.01M | 0.0% |
| D. E. Shaw & Co. | $7.01M | 0.0% |
Ausgestiegen
| Keine erfassten Ausstiege in diesem Quartal. |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 1 Inhaber, 7.50M Anteile, $3.77M gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten — Zählungen gemeinsamer Eigentümerschaft, keine fundamentalen Zusammenhänge.